A SCOTTISH factory is expanding as part of a deal to secure 60 million doses of a coronavirus vaccine candidate developed by the French firm Valneva.

The drugs firm and UK Government are investing in the Livingston plant, with 75 new jobs expected to be created.

If clinical trials are successful, the site could provide up to 100 million doses of the vaccine across the UK and internationally.

Business Secretary Alok Sharma will visit the factory today to hear about plans to scale-up production.

Valneva's vaccine, called VLA2001, is one of four potential vaccines which the UK Government has secured rights for.

Speaking to Good Morning Scotland ahead of his visit, Sharma said the French company hoped to secure regulatory approval for its vaccine in the second half of next year.

Sharma said: "We're looking at a whole range of ways we can support and bring forward a successful vaccine, in addition to that we're also investing in manufacturing in the UK and supporting the international effort."

Valneva said the final supply agreement would be concluded in the coming weeks.